Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

US Pharmaceuticals Ishares ETF (IHE)

US Pharmaceuticals Ishares ETF (IHE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family BlackRock iShares
  • Assets Under Management 357,780,000
  • Shares Outstanding, K 2,000
  • 60-Month Beta 0.93
Trade IHE with:
  • Price/Earnings ttm 27.41
  • Annual Dividend & Yield 2.14
  • Most Recent Dividend 0.526
  • Management Fee 0.42%
  • Sectors:

    ETFs - Biotech

Options Overview

Details
  • Implied Volatility 15.69%
  • Historical Volatility 15.84%
  • IV Percentile 1%
  • IV Rank 2.92%
  • IV High 116.57% on 03/16/20
  • IV Low 12.66% on 02/05/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 12
  • Volume Avg (30-Day) 0
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 10
  • Open Int (30-Day) 0

Price Performance

See More
Period Period Low Period High Performance
1-Month
177.68 +2.71%
on 02/23/21
188.10 -2.98%
on 01/26/21
-2.23 (-1.21%)
since 01/22/21
3-Month
169.66 +7.57%
on 11/25/20
188.10 -2.98%
on 01/26/21
+11.52 (+6.74%)
since 11/24/20
52-Week
115.53 +57.97%
on 03/23/20
188.10 -2.98%
on 01/26/21
+26.64 (+17.09%)
since 02/24/20

Most Recent Stories

More News
Pharma ETFs in Focus Post Q4 Earnings

Healthcare Q4 results seem robust given that it is the fourth-best sector from a revenue growth look and the sixth-strongest in terms of earnings growth.

JNJ : 162.59 (+1.34%)
PFE : 33.75 (-0.47%)
MRK : 74.57 (+0.04%)
LLY : 204.52 (+1.01%)
BMY : 62.59 (+3.08%)
PPH : 68.87 (+1.20%)
PJP : 79.73 (+2.02%)
IHE : 182.50 (+1.95%)
XPH : 55.13 (+2.43%)
FTXH : 26.37 (+1.27%)
JNJ Touches New Highs Post Solid Q4 Earnings: ETFs in Focus

The solid results coupled with upbeat vaccine data optimism pushed JNJ shares to all-time high.

JNJ : 162.59 (+1.34%)
PFE : 33.75 (-0.47%)
MRNA : 144.79 (-3.58%)
XLV : 114.74 (+0.69%)
VHT : 229.54 (+0.80%)
IYH : 250.93 (+0.65%)
IHE : 182.50 (+1.95%)
IEIH : 33.49 (+0.87%)
Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)?

Sector ETF report for PPH

PPH : 68.87 (+1.20%)
NVO : 72.19 (+0.71%)
AZN : 50.10 (+1.60%)
BMY : 62.59 (+3.08%)
PJP : 79.73 (+2.02%)
IHE : 182.50 (+1.95%)
ETFs to Shine on Lilly's Coronavirus Antibody Progress

Eli Lilly's (LLY) progress in antibodies treatment is expected to raise investors' optimism.

PPH : 68.87 (+1.20%)
PJP : 79.73 (+2.02%)
IHE : 182.50 (+1.95%)
XPH : 55.13 (+2.43%)
Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)?

Sector ETF report for PPH

PPH : 68.87 (+1.20%)
NVO : 72.19 (+0.71%)
AZN : 50.10 (+1.60%)
BMY : 62.59 (+3.08%)
PJP : 79.73 (+2.02%)
IHE : 182.50 (+1.95%)
Should You Invest in the SPDR SP Pharmaceuticals ETF (XPH)?

Sector ETF report for XPH

XPH : 55.13 (+2.43%)
RPRX : 47.20 (+0.60%)
HZNP : 95.48 (+13.29%)
PJP : 79.73 (+2.02%)
IHE : 182.50 (+1.95%)
MYOK : 224.91 (+0.05%)
Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)?

Sector ETF report for PPH

PPH : 68.87 (+1.20%)
NVO : 72.19 (+0.71%)
AZN : 50.10 (+1.60%)
BMY : 62.59 (+3.08%)
PJP : 79.73 (+2.02%)
IHE : 182.50 (+1.95%)
Q3 Earnings Fail to Impress Pharma ETFs

The slew of Q3 results have led to mixed trading in pharma ETFs over the past month.

PPH : 68.87 (+1.20%)
PJP : 79.73 (+2.02%)
IHE : 182.50 (+1.95%)
XPH : 55.13 (+2.43%)
FTXH : 26.37 (+1.27%)
ETFs to Shine on Lilly's U.S. Deal for Coronavirus Antibody

Eli Lilly's (LLY) progress in antibodies treatment is expected to raise investors' optimism.

PPH : 68.87 (+1.20%)
PJP : 79.73 (+2.02%)
IHE : 182.50 (+1.95%)
XPH : 55.13 (+2.43%)
Healthcare ETFs: Winners & Losers in the Light of U.S. Election

The coronavirus vaccine development effort has put the spotlight on the U.S. healthcare sector in recent months.

IHI : 335.89 (+0.70%)
IHF : 241.77 (+0.87%)
PJP : 79.73 (+2.02%)
IHE : 182.50 (+1.95%)
XHE : 123.14 (+1.25%)
GNOM : 24.64 (+0.98%)
CNBS : 32.49 (+2.33%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Fund Summary

The iShares U.S. Pharmaceuticals ETF seeks to track the investment results of an index composed of U.S. equities in the pharmaceuticals sector. The Fund seeks investment results that correspond to the price and yield of the Dow Jones U.S. Select Pharmaceuticals Index.

See More

Top 10 Holdings

Key Turning Points

3rd Resistance Point 187.27
2nd Resistance Point 185.35
1st Resistance Point 183.92
Last Price 182.50
1st Support Level 180.57
2nd Support Level 178.65
3rd Support Level 177.22

See More

52-Week High 188.10
Last Price 182.50
Fibonacci 61.8% 160.38
Fibonacci 50% 151.82
Fibonacci 38.2% 143.25
52-Week Low 115.53

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar